In 2023, Sichuan Kelun-Biotech Biopharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Sichuan Kelun-Biotech Biopharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Sichuan Kelun-Biotech Biopharmaceutical amounted to 19,903.34 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
In 2023, the total Scope 1 emissions of Sichuan Kelun-Biotech Biopharmaceutical were 6,335.07 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 13,568.27 tCOâ‚‚e without specifying the calculation method.
In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported its Scope 2 emissions using an unspecified methodology.